Literature DB >> 10986181

Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.

D N Rausch1, G M Lambert-Messerlian, J A Canick.   

Abstract

OBJECTIVE: To determine whether women who have had a positive serum screening result for Down syndrome or neural tube defect in 1 pregnancy have a lower rate of participation in screening in their next pregnancy.
SETTING: A triple-marker screening program at a university hospital.
METHODS: Pregnancy and screening information was collected from laboratory and hospital databases to compare subsequent screening participation of women who were screen-negative and screen-positive for the risk of a fetus with Down syndrome or a neural tube defect.
RESULTS: In an age-matched comparison, 108 women who had a previous screen-positive result were significantly less likely than 108 women who were screen-negative to participate in maternal serum screening in their next pregnancy. When examined according to the type of screen-positive result, the effect was significant for both those who were screen-positive for Down syndrome and those who were screen-positive for neural tube defect. The degree of risk in screen-positive women did not significantly affect their participation in screening in the next pregnancy.
CONCLUSIONS: Anxiety related to a screen-positive result probably causes decreased participation in maternal serum screening in the next pregnancy. Reducing the screen-positive rate in prenatal serum screening would alleviate maternal anxiety and would probably lead to more stable participation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986181      PMCID: PMC1071059          DOI: 10.1136/ewjm.173.3.180

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  21 in total

1.  Prenatal screening for trisomy 18 in the second trimester.

Authors:  J A Canick; G E Palomaki; R Osathanondh
Journal:  Prenat Diagn       Date:  1990-08       Impact factor: 3.050

2.  The psychological impact of false positive elevations of maternal serum alpha-fetoprotein.

Authors:  B K Burton; R G Dillard; E N Clark
Journal:  Am J Obstet Gynecol       Date:  1985-01-01       Impact factor: 8.661

3.  Stress after amniocentesis for high serum alpha-fetoprotein concentrations.

Authors:  W Farrant
Journal:  Br Med J       Date:  1980-08-09

4.  Prenatal screening for Down's Syndrome.

Authors:  A Round; W Hamilton
Journal:  BMJ       Date:  1993-11-06

5.  Anxiety in women with low maternal serum alpha-fetoprotein screening results.

Authors:  D N Abuelo; M R Hopmann; G Barsel-Bowers; A Goldstein
Journal:  Prenat Diagn       Date:  1991-06       Impact factor: 3.050

6.  Low level of maternal serum alpha-fetoprotein: its associated anxiety and the effects of genetic counseling.

Authors:  K L Keenan; D Basso; J Goldkrand; W J Butler
Journal:  Am J Obstet Gynecol       Date:  1991-01       Impact factor: 8.661

7.  Patient attitudes toward testing for maternal serum alpha-fetoprotein values when results are false-positive or true-negative.

Authors:  K J Earley; J D Blanco; S Prien; D Willis
Journal:  South Med J       Date:  1991-04       Impact factor: 0.954

8.  Presenting a routine screening test in antenatal care: practice observed.

Authors:  T M Marteau; J Slack; J Kidd; R W Shaw
Journal:  Public Health       Date:  1992-03       Impact factor: 2.427

9.  The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study.

Authors:  T M Marteau; R Cook; J Kidd; S Michie; M Johnston; J Slack; R W Shaw
Journal:  Prenat Diagn       Date:  1992-03       Impact factor: 3.050

10.  Screening for neural-tube defects and maternal anxiety.

Authors:  J Fearn; B M Hibbard; K M Laurence; A Roberts; J O Robinson
Journal:  Br J Obstet Gynaecol       Date:  1982-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.